| Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate Cancers (NCT03961737) | Institut Cancerologie de l'Ouest | 2019-04-02 |
| A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer (NCT03822871) | Cancer Targeted Technology | 2019-04-01 |
| Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer (NCT04356430) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2019-04-01 |
| [18F]PSMA-11 PET/CT Phase 3 Clinical Study (NCT03911310) | University Hospital, Ghent | 2019-04-01 |
| A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1 (NCT03837353) | NYU Langone Health | 2019-04-01 |
| Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy (NCT03080116) | Universitaire Ziekenhuizen KU Leuven | 2019-03-28 |
| Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer (NCT03793543) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-03-27 |
| Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer (NCT03860272) | Agenus Inc. | 2019-03-20 |
| Feasibility of the LUM Imaging System for Detection of Prostate Cancer (NCT03441464) | Lumicell, Inc. | 2019-03-20 |
| Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency (NCT03716739) | Dana-Farber Cancer Institute | 2019-03-19 |
| MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection (NCT03819751) | Universitaire Ziekenhuizen KU Leuven | 2019-03-18 |
| The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening. (NCT03857477) | Institute of Cancer Research, United Kingdom | 2019-03-14 |
| Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance (NCT03769766) | University of Texas Southwestern Medical Center | 2019-03-11 |
| Multicenter Study of Hypofractionated Postoperative Radiotherapy in Patients Diagnosed With Prostate Carcinoma (NCT04484038) | Grupo de Investigación Clínica en Oncología Radioterapia | 2019-03-09 |
| A Study of Olaparib and Durvalumab in Prostate Cancer (NCT03810105) | Memorial Sloan Kettering Cancer Center | 2019-03-07 |
| A Registry for Hereditary Cancer Risk Assessment and Genetic Testing (NCT04015102) | Myriad Genetic Laboratories, Inc. | 2019-03-06 |
| F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence (NCT04102553) | ABX advanced biochemical compounds GmbH | 2019-03-06 |
| Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer (NCT03677076) | Medical University of South Carolina | 2019-03-04 |
| The Effect of ADT on PSMA Expression in Metastatic Prostate Cancer (NCT03876912) | Turku University Hospital | 2019-03-01 |
| Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance (NCT03579654) | OncBioMune Pharmaceuticals | 2019-02-28 |
| Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery (NCT03824808) | University of Missouri-Columbia | 2019-02-26 |
| Using Virtual Reality (VR) Models for Robotic Prostatectomy - UNC (NCT03870269) | Ceevra, Inc. | 2019-02-25 |
| Prolaris Enhanced Risk Stratification - an ecONomic and clinicAL Evaluation (NCT03851211) | The Leeds Teaching Hospitals NHS Trust | 2019-02-21 |
| CamPROBE: Developing a Safer and Simple Device for Local Anaesthetic Transperineal Prostate Biopsies (NCT03609528) | Cambridge University Hospitals NHS Foundation Trust | 2019-02-15 |
| Interest of Trimodality PET-CT Choline MRI Before Radiotherapy in High Risk Prostate Cancer (NCT03734757) | Centre Henri Becquerel | 2019-02-14 |
| Precision Medicine in the Prostate Cancer Care Pathway (NCT04763317) | Institute of Cancer Research, United Kingdom | 2019-02-14 |
| A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype. (NCT03910660) | BioXcel Therapeutics Inc | 2019-02-12 |
| Involvement of SK3 Calcium Channel in Taxane Neuropathy (NCT03816904) | University Hospital, Tours | 2019-02-06 |
| Adaptive Radiotherapy for High-risk Prostate Cancer Using Multiparametric MRI (NCT03967080) | East and North Hertfordshire NHS Trust | 2019-02-05 |
| Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC (NCT03792841) | Amgen | 2019-02-05 |
| EDRN Prostate MRI Biomarker Study (NCT03784924) | University of Michigan | 2019-02-04 |
| Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancer (NCT03623425) | Central Hospital, Nancy, France | 2019-02-01 |
| Deep Learning for Prostate Segmentation (NCT04191980) | Hospices Civils de Lyon | 2019-02-01 |
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (NCT04075305) | UMC Utrecht | 2019-02-01 |
| Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms (NCT06065592) | Lebanese University | 2019-02-01 |
| Robotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate Biopsy (NCT05022576) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2019-01-30 |
| Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer (NCT02789878) | Instituto do Cancer do Estado de São Paulo | 2019-01-24 |
| MR-based Hypofractionated Adaptive IGRT of Prostate Cancer (M-base HyPro 2.0) (NCT03880851) | University Hospital Tuebingen | 2019-01-23 |
| MRI Prostate for Chinese Men Being Screened for Prostate Cancer (NCT03891732) | Chinese University of Hong Kong | 2019-01-19 |
| Testosterone Therapy in Castration Resistant Prostate Cancer (NCT03734653) | University of Colorado, Denver | 2019-01-18 |
| Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients (NCT03712371) | Medical University of South Carolina | 2019-01-16 |
| Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR) (NCT03807492) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2019-01-16 |
| To Identify Potential New Urine Markers for the Screening of Prostate Cancer (NCT03914391) | Chinese University of Hong Kong | 2019-01-16 |
| Clinical Trial for a Robotic Endomicroscopy to Better Define Resection Strategies Applied to Urology Surgery (NCT03561857) | Mauna Kea Technologies | 2019-01-16 |
| 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer (NCT03809078) | Andrei Iagaru | 2019-01-14 |
| Therapeutic Efficiency and Response to 2.0 GBq (55mCi) 177Lu-EB-PSMA in Patients With mCRPC (NCT04996602) | Peking Union Medical College Hospital | 2019-01-14 |
| The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer (NCT03808077) | Memorial Sloan Kettering Cancer Center | 2019-01-14 |
| A Survivorship Care Plan and Embedded Navigation Tool (NCT03424837) | Duke University | 2019-01-11 |
| Evaluation of a MRI-based Prostate Cancer Screening Program (NCT03749993) | University Hospital, Basel, Switzerland | 2019-01-10 |
| PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer (NCT03768349) | Mayo Clinic | 2019-01-03 |
| PET/MRI Study of Men With Highly Suspicious MRI Lesions That Showed no Clinically Significant Prostate Cancer Following MRI Fusion Targeted Biopsy (NCT03635866) | NYU Langone Health | 2019-01-02 |
| Using Virtual Reality (VR) Models for Robotic Prostatectomy (NCT03943368) | Ceevra, Inc. | 2019-01-01 |
| a Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitY (NCT04290611) | Groupe Hospitalier Pitie-Salpetriere | 2019-01-01 |
| Ability of Cardio Q for Prediction of Hypotension (NCT03882697) | Severance Hospital | 2019-01-01 |
| Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency (NCT03580239) | Tianjin Medical University Second Hospital | 2019-01-01 |
| Robot-assisted vs Laparoscopic Radical Prostatectomy for Prostate Cancer Treatment (NCT04011865) | Binh Dan Hospital | 2019-01-01 |
| MRI-guided Focal Laser Ablation (NCT04379362) | Radboud University Medical Center | 2018-12-14 |
| The "PC-LIGHT" Study (NCT03419585) | Northwestern University | 2018-12-12 |
| Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients (NCT03787056) | Hospices Civils de Lyon | 2018-12-04 |
| Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients (NCT03630666) | Institut Cancerologie de l'Ouest | 2018-12-04 |
| Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer (NCT03753243) | Mark Garzotto, MD | 2018-12-03 |
| PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer (NCT03594760) | Centre hospitalier de l'Université de Montréal (CHUM) | 2018-12-01 |
| Urology San Antonio MRI/MicroUS Comparison (NCT03762616) | Exact Imaging | 2018-11-28 |
| Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (NCT03739684) | Progenics Pharmaceuticals, Inc. | 2018-11-27 |
| A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer (NCT03706365) | Eli Lilly and Company | 2018-11-26 |
| Nutrition and Prostate Cancer (NCT03532308) | Yale University | 2018-11-21 |
| A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC (NCT03741712) | Jiangsu HengRui Medicine Co., Ltd. | 2018-11-20 |
| Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer (NCT03748719) | H. Lee Moffitt Cancer Center and Research Institute | 2018-11-19 |
| Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancer (NCT03689582) | University of Michigan Rogel Cancer Center | 2018-11-13 |
| The Effect of Androgen Deprivation Therapy on Gut and Urinary Microbiota in Patients With Prostate Cancer (NCT03888742) | Chinese University of Hong Kong | 2018-11-12 |
| Single Fractions SBRT for Prostate Cancer (NCT04004312) | Fabio Cury | 2018-11-07 |
| Predicting Prostate Biopsy Results With Biomarkers and mpMRI. (NCT03730324) | Torben Brøchner Pedersen | 2018-11-05 |
| Evaluation of Gut Microbiome in Patients With Prostate Cancer (NCT03709485) | Ziv Hospital | 2018-11-01 |
| Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer (NCT04794777) | Stefan Carlsson | 2018-10-30 |
| PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT) (NCT03663218) | Weill Medical College of Cornell University | 2018-10-24 |
| Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy (NCT03725761) | University of Wisconsin, Madison | 2018-10-24 |
| Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer (NCT03674814) | University of Chicago | 2018-10-23 |
| Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones. (NCT03630926) | Intermountain Health Care, Inc. | 2018-10-16 |
| Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients (NCT03803475) | Thomas Hope | 2018-10-11 |
| Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) (NCT03689699) | Mark Stein | 2018-10-11 |
| Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT (NCT04081428) | NHS Lothian | 2018-10-11 |
| ClariCore System Used in Transperineal Prostate Biopsy (NCT03734575) | Precision Biopsy, Inc. | 2018-10-10 |
| Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer (NCT04000464) | University of Arizona | 2018-10-09 |
| Prostasomes as Diagnostic Tool for Prostate Cancer Detection (NCT03694483) | Hackensack Meridian Health | 2018-10-03 |
| Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy (NCT03543189) | H. Lee Moffitt Cancer Center and Research Institute | 2018-10-03 |
| Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men (NCT04108871) | The University of Hong Kong | 2018-10-03 |
| Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer (NCT03531099) | Hospices Civils de Lyon | 2018-10-02 |
| Optimal Prostate Study (NCT03386045) | Royal North Shore Hospital | 2018-10-02 |
| Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions (NCT03477591) | McMaster University | 2018-10-01 |
| Upright MRI for Prostate Cancer Screening (NCT03474913) | Icahn School of Medicine at Mount Sinai | 2018-10-01 |
| The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy. (NCT03675529) | Rigshospitalet, Denmark | 2018-10-01 |
| Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer (NCT03568188) | Hospices Civils de Lyon | 2018-09-28 |
| HIFU for Focal Ablation of Prostate Tissue: An Observational Study (NCT03620786) | University of California, Los Angeles | 2018-09-26 |
| Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance (NCT03679260) | Cedars-Sinai Medical Center | 2018-09-25 |
| Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose (NCT03440879) | Norwegian School of Sport Sciences | 2018-09-21 |
| Cisplatin in Castration Resistant Prostate Cancer (NCT03275857) | University of Rochester | 2018-09-21 |
| Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer (NCT03511196) | H. Lee Moffitt Cancer Center and Research Institute | 2018-09-17 |
| A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death (NCT03619980) | Astellas Pharma Europe Ltd. | 2018-09-13 |
| Prostate Cancer Patients Treated With Alternative Radiation Oncology Strategies (NCT04083937) | University Hospital Heidelberg | 2018-09-12 |
| pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer (NCT03600350) | University of Wisconsin, Madison | 2018-09-10 |